4d837ccf73bd2e39…

{
  "id": "NCT00056225",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to determine whether reduction of homocysteine levels with high-dose folate (folic acid), B6, and B12 supplementation will slow the rate of cognitive decline in persons with Alzheimer's disease.",
    "completionDate": "2007-06",
    "conditions": [
      "Alzheimer's Disease"
    ],
    "enrollmentCount": 340,
    "enrollmentType": "ACTUAL",
    "nctId": "NCT00056225",
    "phase": "PHASE3",
    "sponsorId": "national-institute-on-aging-nia",
    "startDate": "2003-01",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)",
    "url": "https://clinicaltrials.gov/study/NCT00056225"
  }
}